Kindeva Hollow Microstructured Transdermal System
Source: Kindeva Drug Delivery
Powerful cancer vaccines are one part of the cancer treatment puzzle. Kindeva Hollow Microstructured Transdermal System (hMTS) is designed to help your vaccine reach its treatment potential through intradermal delivery. It’s time to approach clinical trials with confidence.
Why intradermal delivery?
- Potential for enhanced immune response
Why Kindeva hMTS?
- Easy, consistent, reproducible intradermal delivery
- Higher volumes vs. other intradermal delivery devices
access the Brochure!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.
Subscribe to Outsourced Pharma
X
Subscribe to Outsourced Pharma
This website uses cookies to ensure you get the best experience on our website. Learn more